Evidence, outputs and translational momentum
Proof of capability at AHERF-CMBRC comes from publications, funded programs, patents, collaborations, training activity, centres and platform-linked translational outputs.
Show peer-reviewed outputs by disease area, platform relevance and translational contribution.
Show funder confidence, project scope, AHERF-CMBRC role and expected translational outcome.
Show invention areas, collaboration networks, standards activity and partner-ready evidence.
Impact combines academic, translational and institutional outputs across scientific programs, training, collaborations and evidence generation.
- Scientific publications.
- Grants and funded projects.
- Patents and intellectual property.
- Clinical cohorts and validation studies.
- Workshops and training programs.
- Industry and academic collaborations.
- Centres, networks and standards-building activity.
Publication entries should highlight title, authors, journal/year, disease area, platform relevance and the translational contribution.
| Evidence field | Public-facing use |
|---|---|
| Title and authors | Identify the scientific output and contributor network. |
| Journal / year / DOI | Give readers a verifiable route to the publication. |
| Disease area | Show relevance to neurology, oncology, renal, ophthalmology, metabolic or other programs. |
| Platform relevance | Connect the output to EV, biomarker, AI, validation, liquid biopsy or multi-omics capability. |
Grant content demonstrates funder confidence, execution capability and translational relevance.
- Grant title.
- Funding agency.
- Role of AHERF-CMBRC.
- Scientific area.
- Translational outcome or expected deliverable.
Patents should support the discovery-to-translation story without overclaiming commercial or regulatory status.
- Patent family.
- Technology domain.
- Clinical or commercial relevance.
- Stage: filed, published, granted, PCT or national phase.
- Related platform or disease area.
Collaborations span academic, industry, clinical, institutional and standards-linked networks.
- Academic collaborations.
- Industry partnerships.
- Clinical consortia.
- MoUs and institutional partnerships.
- Standards and society-linked activity.
Events and workshops show active capacity building and community leadership. Public AHERF material includes EV and exosome-focused training, including “From Sample - Signal: Exosome Diagnostic Workflows,” a 2026 workshop on EV-based liquid biopsy, isolation, multimodal characterization, nano-flow cytometry and digital PCR.
- Scientific conferences.
- Hands-on EV and liquid biopsy workshops.
- Digital PCR and multimodal characterization training.
- Standards and quality-focused sessions.
- Clinician-scientist engagement events.
Centres, networks and ecosystem-building initiatives reflect AHERF-CMBRC’s role in translational research, training and standards-oriented collaboration.
- EV ecosystem activities.
- Centre of Excellence activities.
- Clinical consortia.
- Standards and training networks.
Explore collaboration through evidence
Review verified outputs and discuss the next translational opportunity.
Partner with CMBRC